Photo: AP Images
Novartis takes a hit as FDA orders a hold on Zolgensma trials in wake of fresh safety concerns
The FDA has ordered Novartis to halt enrollment and dosing in a set of trials for Zolgensma, their gene therapy for lethal cases of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
